Acute lymphoblastic leukaemia (ALL) is the most common malignancy in children. The 5-year survival rate has gradually increased from 5% in early 1970s to over 80% today. Until now most patients have been discharged from further follow up after puberty. The general aim of this thesis was to investigate long-term side effects in a homogenous group of young adult survivors of childhood ALL.Thirty-five young adults in the age 20-32 years, who had been treated for ALL before puberty, were investigated. They had all received chemotherapeutic treatment and corticosteroids. Nineteen had received a low dose prophylactic radiotherapy to the central nervous system (18-24 Gy).In spite of little or no effect on final height we found low spontaneous GH s...
Objective: Treatment for childhood leukaemia induces many risk factors for development of decreased ...
To determine whether obesity complicated the treatment of childhood acute lymphoblastic leukemia, we...
Objective: Survival rates for childhood acute lymphoblastic leukemia (ALL) have significantly improv...
BACKGROUND: Treatments of acute lymphoblastic leukaemia (ALL) and non-Hodgkin lymphoma (NHL), involv...
BACKGROUND. The purpose of the study was to determine the prevalence of metabolic syndrome, growth h...
One aim of the long-term care in survivors from acute lymphoblastic leukemia (ALL) during childhood ...
BACKGROUND. The purpose of the study was to determine the prevalence of metabolic syndrome, growth ...
BACKGROUND. The purpose of the current study was to determine the prevalence of low bone mineral de...
Objective: To evaluate long-term growth and final height (FH) in survivors of childhood acute lympho...
none7Reduction of adult height is a well-recognized complication in long-term ALL survivors who rece...
BACKGROUND. The purpose of the current study was to determine the prevalence of low bone mineral den...
Background: The prevalence of low bone mineral density (BMD) in adult survivors of childhood acute l...
Abstract Background To reduce the risk of brain damage children with acute lymphoblastic leukaemia (...
OBJECTIVE: Bone mineral density (BMD) in survivors of acute lymphoblastic leukaemia (ALL) seems to v...
Abstract Background To reduce the risk of brain damage children with acute lymphoblastic leukaemia (...
Objective: Treatment for childhood leukaemia induces many risk factors for development of decreased ...
To determine whether obesity complicated the treatment of childhood acute lymphoblastic leukemia, we...
Objective: Survival rates for childhood acute lymphoblastic leukemia (ALL) have significantly improv...
BACKGROUND: Treatments of acute lymphoblastic leukaemia (ALL) and non-Hodgkin lymphoma (NHL), involv...
BACKGROUND. The purpose of the study was to determine the prevalence of metabolic syndrome, growth h...
One aim of the long-term care in survivors from acute lymphoblastic leukemia (ALL) during childhood ...
BACKGROUND. The purpose of the study was to determine the prevalence of metabolic syndrome, growth ...
BACKGROUND. The purpose of the current study was to determine the prevalence of low bone mineral de...
Objective: To evaluate long-term growth and final height (FH) in survivors of childhood acute lympho...
none7Reduction of adult height is a well-recognized complication in long-term ALL survivors who rece...
BACKGROUND. The purpose of the current study was to determine the prevalence of low bone mineral den...
Background: The prevalence of low bone mineral density (BMD) in adult survivors of childhood acute l...
Abstract Background To reduce the risk of brain damage children with acute lymphoblastic leukaemia (...
OBJECTIVE: Bone mineral density (BMD) in survivors of acute lymphoblastic leukaemia (ALL) seems to v...
Abstract Background To reduce the risk of brain damage children with acute lymphoblastic leukaemia (...
Objective: Treatment for childhood leukaemia induces many risk factors for development of decreased ...
To determine whether obesity complicated the treatment of childhood acute lymphoblastic leukemia, we...
Objective: Survival rates for childhood acute lymphoblastic leukemia (ALL) have significantly improv...